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PARKINSON’S DISEASE
• A neurodegenerative disease of the basal ganglia
• Caused by dopamine depletion (DeMaagd & Philip, 2015)
• 1-3% of people older than 80 years old (DeMaagd & Philip, 2015)
• Symptoms
• Tremors
• Muscular rigidity
• Bradykinesia
• Dementia
https://en.wikipedia.org/wiki/Pathophysiology_of_Parkinson%27s_disease
http://cuteurl.info/wwelinfo-liraglutide-parkinson-
2018.html
THE BASAL GANGLIA
• Basal Ganglia
• A collection of nuclei
• Substantia Nigra
• Subthalamic Nucleus
• External Globus Pallidus
• Striatum
• Areas of interest
• Striatum
• External Globus Pallidus
https://www.mayfieldclinic.com/PE-PD.htm
SPINY PROJECTION NEURONS
• Neurons of the Striatum (Surmeier et al., 2007)
• Sometimes referred to as Medium Spiny Neurons
• Two main classes of receptors: D1 and D2 receptors (Surmeier et al., 2007)
• Direct and Indirect SPNs
PALLIDOSTRIATAL PATHWAY
• Striatal input to GPe is inhibitory 
(Jaeger et al., 2011)
• GPe input to Striatum is 
inhibitory (Jaeger et al., 2011)
• Npas1+ GPe neurons project to 
the Str (Hernandez et al., 2016)
https://beyondthedish.wordpress.com/tag/striatum/
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MATERIALS AND METHODS
• Parkinsonian Mice
• Symptoms produced using 6-
hydroxydopamine (6-OHDA)
• 6-OHDA injected into the 
brain
• Destroys dopaminergic 
neurons of the substantia 
nigra
• Induces symptoms of 
Parkinson’s Disease
https://www.creative-biolabs.com/drug-discovery/therapeutics/6-ohda-unilateral-lesion-rat-model-of-parkinson-s-disease.htm
MATERIALS AND METHODS
• Data Collection
• Transgenic mice brain slices
• Npas1-Cre;D2-GFP
• Whole Cell Patch Clamping
• Fluorescent Dye (Alexa 647 
hydrazide)
• Surrounding GPe axons
• YFP+ (visualized in the 488 nm 
range)
• Protein Fluoresce
• Confocal Microscopy
MATERIALS AND METHODS
• Fiji ImageJ software
• Pallidostriatal contacts
• Between SPN dendrites and 
axons of the GPe
• Verified in the orthogonal 
plane
• Contacts measured via two 
methods
• Euclidian distance calculated
• Trace of dendrite to soma
GENERAL LOCATION OF SYNAPSES
GENERAL BRANCH ORDER AND LOCATION 
OF SYNAPSES
BRANCH ORDER FOR EACH GROUP OF SPNS
GENERAL BRANCH ORDER AND LOCATION 
OF SYNAPSES
CONTACTS PER CELL
D1 SPNs D2 SPNs
Naive 6.9 contacts 7.1 contacts
Lesioned 6.3 contacts 7.1 contacts
NAÏVE GROUP PROJECTIONS
LESIONED GROUP PROJECTIONS
WEAKENED PROJECTIONS OF D1 SPNS
STRONGER PROJECTIONS OF D2 SPNS
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INDIRECT STRIATAL AND PALLIDAL PATHWAYS
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SUMMARY
• Most synapses occurred on 2’ and 3’ dendrites
• Inhibits cortical excitatory input
• Most synapses occurred on the dendritic shaft
• The frequency of synapses was unaffected.
• The projections of the iSPNs are increased in the lesioned 
model. 
• Further inhibits cortical excitatory input
• The projections of the dSPNs are diminished in the lesioned 
model. 
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